Kar et al. identified individuals with CH using whole-exome sequencing of 200,453 UK biobank participants and observed a higher genetically predicted body mass index (BMI) in individuals with larger CH clones and an increased presence of circulating apolipoprotein B in those with TET2-CH clones[26]. The gene discussed is TET2; the disease is cyclic hematopoiesis.